Sarah L Clarke's research while affiliated with University of London and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (2)


Table 1 Percentage of cells in splenic lymphocyte subsets
Figure 3: Defects in Rae-1-targeted natural cytotoxicity in vivo.(a) To compare the killing of Rae-1+ splenocytes relative to normal splenocytes in vivo, cells were differentially labeled CFSEhi and CFSElo, injected intravenously in equal ratios, and after 10 h ratios of cells recovered from spleens were measured by flow cytometry. Left, distinguishable fluorescence intensities of spleen cells from NLC mice labeled CFSElo, from B-actin:Rae-1 transgenic mice (line 187) labeled CFSEhi, and in the mix ratio (52−46%) before injection. Middle and right, ratios of the two CFSE-positive populations recovered from spleens of untreated NLC mice (middle) and transgenic mice of the 121 and 187 lines without (middle) and with (right) prestimulation with poly(I:C). Data are from representative individual mice representing results of three or more sets of experiments. Numbers above boxed areas or bracketed lines indicate the percentage of cells in that area. (b) Top, NKG2D expression on DX5+ splenic NK cells from mice with the reverse tetracycline-dependent transactivator (rtTA) under control of a -actin gene promoter (line 356), mice with tet-responsive promoter-driven Rae-1 only (line 166) and 'bitransgenic' mice (biTG*, from intercross of lines 356 and 166) after 1 week of doxycyline in the diet. NKG2D was measured by staining with CX5 (filled) as compared to isotype control (open). Numbers in top right corners, MFI for filled histograms. *, data represent the majority of mice that were fully responsive to drug (see graphs below and c). Bottom, percentage specific killing of Rae-1 targets calculated from ratios measured as described in a. n, number of independent mice tested. *, biTG mice were divided into two groups based on extent of NKG2D downregulation. (c) Correlation of NKG2D MFI with in vivo cytolytic activity from b. Linear coefficient comparing trend of all individuals, R 2 = 0.72.
Figure 4: In vivo stimulation of NK cells by poly(I:C) restores impaired natural cytotoxicity responses to Rae-1+ targets and MHClo targets.(a) Calculated percent specific lysis of Rae-1 targets from three independent in vivo cytotoxicity experiments either 10 h (circles and triangles) or 6 h (squares) after injection of CFSE-labeled cells as described in a. (b) Calculated percent specific lysis of B2m-/- targets measured in various C57BL/6 F1 transgenic strains (below graph) 10 h after intravenous injection of equal ratios of CFSEhi labeled B2m-/- splenocytes and CFSElo cells from wild-type C57BL/6 spleens. (c) Calculated percent specific lysis of differentially labeled RMA-S thymoma cells (CFSEhi) relative to that of RMA thymoma cells (CFSElo) 48 h after intraperitoneal injection in transgenic and NLC C57BL/6 F1 mice. For all sets of experiments, n indicates the number of independent mice tested for each condition.
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
  • Article
  • Full-text available

October 2005

·

269 Reads

·

417 Citations

Nature Immunology

David E Oppenheim

·

·

Sarah L Clarke

·

[...]

·

Upregulation of the inducible gene products MICA (human) and Rae-1 (mouse) may promote tumor surveillance and autoimmunity by engaging the activating receptor NKG2D on natural killer (NK) cells and T cells. Nevertheless, sustained expression of MICA by tumors can also elicit NKG2D downregulation, perhaps indicating 'immunoevasion'. Investigating this paradox, we report here that constitutive Rae-1epsilon transgene expression in normal epithelium elicited local and systemic NKG2D downregulation, generalized but reversible defects in NK cell-mediated cytotoxicity and mild CD8(+) T cell defects. The extent of NKG2D downregulation correlated well with the incidence and progression of cutaneous carcinogenesis, emphasizing the utility of NKG2D as a marker of tumor resistance. Thus, NKG2D engagement is a natural mediator of immunosurveillance, which can be compromised by locally sustained ligand expression but potentially restored by innate immune activation.

Download
Share

The Integration of Conventional and Unconventional T Cells that Characterizes Cell‐Mediated Responses

February 2005

·

79 Reads

·

76 Citations

Advances in Immunology

This review builds on evidence that cell-mediated immune responses to bacteria, viruses, parasites, and tumors are an integration of conventional and unconventional T-cell activities. Whereas conventional T cells provide clonal antigen-specific responses, unconventional T cells profoundly regulate conventional T cells, often suppressing their activities such that immunopathology is limited. By extrapolation, immunopathologies and inflammatory diseases may reflect defects in regulation by unconventional T cells. To explore the function of unconventional T cells, several extensive gene expression analyses have been undertaken. These studies are reviewed in some detail, with emphasis on the mechanisms by which unconventional T cells may exert their regulatory functions. Highlighting the fundamental nature of T-cell integration, we also review emerging data that the development of conventional and unconventional T cells is also highly integrated.

Citations (2)


... While conventional T cells deliver clonal antigen-specific responses, unconventional T cells play a significant role in modulating conventional T cells. They frequently exert suppressive effects on these cells, limiting immunopathological responses [122]. Gaining a comprehensive understanding of the mechanistic function of γδ T cells in various cancer models has the potential to advance significantly our knowledge not only of the functions of conventional T cells but also to introduce innovative therapeutic approaches. ...

Reference:

Landscape of unconventional γδ T cell subsets in cancer
The Integration of Conventional and Unconventional T Cells that Characterizes Cell‐Mediated Responses
  • Citing Article
  • February 2005

Advances in Immunology

... There are currently three clinical trials (NCT04717999, NCT04270461, NCT04550663) incorporating NKG2D into CAR-T-cells for killing NKG2DL+ glioma [192]. NKG2D-targeted therapy is currently hindered by the fact that tumor cells will express a high level of soluble NKG2DL in place of surface NKG2DL, which results in the desensitization in NKG2D effector cells and impaired antitumoral activity [192][193][194]. ...

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

Nature Immunology